2023 Was a tricky 12 months for that biopharma market, with several providers downsizing and restructuring their workforces to stay afloat. You'll find indications of recovery, as mergers and acquisitions picked up through the pharmaceutical and everyday living sciences field from the latter Portion of 2023 and also have continued https://sites.google.com/view/bio-sites/blog